The results of immunoblot analyses showed that xeroderma pigmentosum, complementation group C (XPC), and damage-specific DNA binding protein 2 (DDB2) in the NER pathway could not be induced after MMC treatment (Figure 3A). The gene discussed is DDB2; the disease is xeroderma pigmentosum.